SR-16435 is a drug which acts as a potent partial agonist at both the ü-opioid receptor and nociceptin receptor. In animal studies it was found to be a potent analgesic, with results suggestive of reduced development of tolerance and increased activity against neuropathic pain compared to classic ü-selective agonists.